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Screening available for 
heredity bleeding disorder in 
Kerry blue terriers
Coagulation factor XI (FXI) deficiency, a heredity
bleeding disorder, was first described in the Kerry blue
terrier in the 1980s. Since then affected dogs have been
recognized regularly, but the distribution and frequency of
this disorder is unknown in Kerry blue terriers.The defect
is inherited by an autosomal trait with dogs homozygous
and possibly heterozygous having an excessive bleeding
tendency.The mutation causing FXI deficiency in Kerry
blue terriers has
very recently been
identified at Penn,
which is now
offering the
opportunity to
screen Kerry blue
terriers at risk for
this mutation.
Dogs with
hereditary FXI
deficiency may
exhibit an
increased bleeding
tendency
following trauma
or surgery (even
after too-short nail clippings or simple surgical skin-mass
removals) or rarely appear to develop spontaneous
bleeding. Some FXI-deficient dogs may bleed excessively
after one event, but not others. Furthermore, as some dogs
remain completely asymptomatic, the diseased/mutant
gene may be unknowingly passed on to the next
generation, not only via heterozygous but also
homozygous affected dogs. Carriers or heterozygotes have
one mutant and one normal gene, and homozygous
animals have two mutant copies of the diseased gene.
Homozygously affected animals are believed to have a
more severe bleeding tendency.
Screening Kerry blue terriers with a clotting test may
suggest FXI deficiency to a veterinarian, and measurement
of low plasma FXI coagulant activity could confirm a
diagnosis of FXI deficiency at a reference laboratory.
However, coagulation tests generally require blood
collection in citrated tubes, which are immediately
separated and shipped, making it impractical as a simple
screening test. Only a small number of Kerry blue terriers
have been tested, and hence the frequency and bleeding
tendency are as yet unknown.
Drs. Eva Tcherneva, research associate, and Urs
Giger, Charlotte Newton Sheppard Professor and chief of
Section of Medical Genetics, have developed and made
available at their laboratory a mutation-based DNA test to
screen for FXI deficiency in Kerry blue terriers.This test
can clearly identify homozygous and heterozygous
affecteds, as well as normal Kerry blue terriers.They
recommend testing any Kerry blue terrier with signs of
bleeding, as well as its relatives. Furthermore, screening
these terriers prior to breeding is advisable to limit the
spread of this disorder, particularly via any popular sires.
Carriers still can be used in future breeding programs, but
identifying carriers will allow the targeted breeding of
carriers with desirable traits to normal dogs, without
producing homozygous affected dogs, as long as the
offspring are also tested and only unaffected dogs used
thereafter.
The School’s Josephine Deubler Genetic Testing
Laboratory offers screening for FXI deficiency in Kerry
blue terriers. Samples suitable for this DNA test include 1-
2 ml EDTA-anticoagulated blood (preferable) or 2–3
cheek swabs (with special cytobrushes). Brushes and test
submission forms are available from the lab
(www.vet.upenn.edu/penngen), through the United States
Kerry Blue Terrier Club (www.uskbtc.com) or Kerry Blue
Terrier Foundation (www.kerryblues.info). For more
information on canine FVII deficiency and for screening
materials, please contact Dr. Giger (215-898-8894 or 
-8830; penngen@vet.upenn.edu).The original studies and
the DNA screening are supported in part by the Kerry
Blue Terrier Foundation, the National Institutes of Health
and some owners and breeders of Kerry blue terriers.
Are Owners Who Relinquish Dogs
Truthful about Their Pets’ Behavior?
A paper entitled
“Evaluation of a
behavioral assess-
ment questionnaire
for use in the
characterization of
behavioral prob-
lems of dogs relin-
quished to animal
shelters”—coau-
thored by Dr.
James Serpell,
Marie A. Moore
Professor of
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Humane Ethics and Animal Welfare and director of the
Center for the Interaction of Animals and Society, and
colleagues from the University of California–Davis—
appeared in the December 2005 issue of the Journal of the
American Veterinary Medical Association.The goal of the
study was to evaluate the accuracy of a behavioral intake
questionnaire given to owners leaving their dogs at 
shelters.
Animals participating in the study were 54 dogs being
relinquished to a shelter and 784 dogs belonging to clients
of the Ryan Veterinary Hospital.The owners leaving ani-
mals at shelters were split into two groups: one was guar-
anteed that all information regarding the animal would be
kept confidential, and the other was told information
would be shared with shelter staff. Compared with the
client owned–group data, significantly more relinquished
shelter dogs in the confidential group were reported to
have owner-directed aggression, stranger-directed aggres-
sion, dog-directed aggression or fear, stranger-directed fear,
nonsocial fear and separation-related behaviors. Results
suggest that behavioral questionnaires may sometimes pro-
vide inaccurate information in a shelter setting, but the
information may still be useful when evaluating behavior
of relinquished dogs.
MRI a Useful Tool in Diagnosing
Masses in Dogs
With funding supplied by the Morris Animal Foundation,
Dr. Chick Weisse,V’98, assistant professor of soft tissue
surgery, and Dr. Craig Clifford, former resident of oncolo-
gy at the Ryan Veterinary Hospital, found that magnetic
resonance imaging is extremely useful as a diagnostic tool
for dogs with liver and splenic masses. Using MRI
sequences, scientists can see how much a cancer has
spread, giving owners an option of foregoing surgery in
favor of MRI.
A New Way to Relieve 
Pain in Dogs
Dr. Dottie Brown, assistant professor of surgery at the
Ryan Veterinary Hospital, participated in a study
examining new ways to help relieve the pain of dogs with
cancer or arthritis.The results show some unusual and
unexpected pain-management properties of a compound
called resiniferatoxin
(RTX), a red-hot
sap produced by a
Moroccan cousin 
of the chili pepper
plant.
Researchers at
the National
Institutes of Health
in an attempt to
better understand
pain in human
beings discovered
that, in cancer
patients, pain
messages were sent
to the brain by
certain nerve cells in
the spine. But these
nerve cells, the
researchers found,
could be killed if
infused with
calcium—and once
killed, the pain
messages could be
stopped.When
RTX—about 1,000
times more potent
than the capsaicin that makes chili peppers hot—comes
into contact with the pain-transmitted nerve cells, it spurs
a rush of calcium into the cells, destroying them and
providing relief from the pain of cancer.
The NIH team found RTX seemed to work on lab
animals, but needed more evidence to support their claim.
And because humans and dogs are so similar, medically
speaking, they turned to Dr. Brown, whose work had put
her in contact with dogs suffering from severe cancer
pain. Dr. Brown then selected dogs that might make 
good case studies. She chose a group diagnosed with
cancer that were so painful they were unable to put
weight on their limbs.
After taking injections of RTX, the same dogs could
run and jump almost as if they felt no pain at all.The
cancer persisted—and eventually proved fatal—but owners
reported weeks or months of good times after RTX
treatment.The initial trial was such a success that Dr.
Brown will conduct another, more thorough study this
summer. Meanwhile, the NIH team is pushing to begin
testing RTX on humans soon.
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Students from the Beta Chapter of Phi Zeta Veterinary Honor Society recently presented research papers at the School of
Veterinary Medicine.Abstracts from the student presentations can be found at www.vet.upenn.edu/bellwether/researchbriefs.
